Rohto Pharmaceutical Co (JP:4527) has released an update.
Rohto Pharmaceutical Co. reports an increase in consolidated net sales by 11.7% year-on-year for the first quarter of FY2025, with a slight dip in profit attributable to owners by 6.7%. The company’s total assets have grown, and there has been a revision to the dividend forecast, with an expected annual dividend of 33 yen per share. The financial forecast for the full year anticipates continued growth in sales and profits.
For further insights into JP:4527 stock, check out TipRanks’ Stock Analysis page.
